Term
| Oropharyngeal: Preferred: |
|
Definition
| Fluconazole (Diflucan) 100 mg po daily x 7-14 days |
|
|
Term
| Oropharyngeal: Maintenance |
|
Definition
| Fluconazole 100 mg PO TIW |
|
|
Term
| Esophageal Candidiasis: Preferred Txt |
|
Definition
| Fluconazole 100 mg (up to 400 mg) po or IV daily x 14-21 days |
|
|
Term
| Esophageal Candidiasis: Maintenance |
|
Definition
| Fluconazole 100-200 mg PO QD |
|
|
Term
| Vulvovaginitis: Preferred |
|
Definition
| Fluconazole 150 mg PO x 1 day or topical azoles for 3-7 days |
|
|
Term
| Vulvovaginitis Mainteance |
|
Definition
| fluconazole 150 mg po weekly |
|
|
Term
| PCP Preferred Prophylaxis |
|
Definition
| SMX/TMP 1 DS (or SS) PO QD; also start if fever > 100 F or thrush present; Stop when CD4 > 200 for > 3 months |
|
|
Term
|
Definition
| Sulfadiazine IV (wt based) + pyrimethamine PO (wt based) + leucovorin PO x 6 weeks |
|
|
Term
| Toxoplasmosis Primary Prophylaxis |
|
Definition
| SMX/TMP 1 DS (or SS) PO QD; Stop when CD4 >200 for 3 months on art; Restart when CD4 < 100-200 |
|
|
Term
|
Definition
| Clarithromycin 500 mg PO BID or (azithromycin if can't tolerate) + Ethambutol 15 mg/kg PO QD; Treat for life unless immune reconstitution |
|
|
Term
| MAC Txt Preferred Prophylaxis |
|
Definition
| Azithromycin 1200 mg PO Q week or 600 mg PO BIW; Stop when > 100 for > 3 mo with sustained suppression on ART |
|
|
Term
| Cytomegalovirus (CMV) Txt |
|
Definition
| most likely will need systemic therapy; unilateral retinitis commonly will spread; induction: higher dose more frequent; maintenance: less often, possibly life-long |
|
|
Term
| CMV Acute Txt - Induction |
|
Definition
| Ganciclovir (cytovene) 5 mg/kg IV ID 14-21 days or Valcyte valganciclovir 90 mg po BID x 21 days |
|
|
Term
|
Definition
| Ganciclovir IV 5 mg/kg daily; Valganciclovir (Valcyte) 900 mg PO daily; |
|
|
Term
|
Definition
| High Dose SMX/TMP IV/PO; 15-20 mg/kg TMP/day divided Q 6-8 h x 21 days + Prednisone or methylpred x 21 days |
|
|
